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Abstract
Studies worldwide indicate that oral enzyme therapy (OET) can prevent or reduce
the side effects associated with standard oncology care. Yet use of OET is not common
in the United States. The ultimate aim of the proposed project is to improve the quality
of life of women with breast cancer who are on standard chemotherapy protocols.
Achieving this goal can be facilitated by implementation of the proposed feasibility
project designed to: (a) enhance the knowledge of oncology care providers and women
with breast cancer on use of OET in conjunction with standard oncology care, (b) assess
the attitudes of oncology care providers and women with breast cancer regarding use of
OET, and (c) establish relationships with providers in the oncology care community and
groups for women with breast cancer.
An educational program entitled “Enzyme Nutrition in Oncology Care” was
developed and implemented in the project setting. Six programs were conducted with
women with breast cancer, their support persons and the general public. Four programs
were conducted with oncology care provider groups. An enzyme knowledge test was
administered to program attendees in a pre-test/post-test fashion. Analysis of scores on
the post-test when compared to the pre-test demonstrate that the knowledge base
regarding oral enzyme therapy use in conjunction with standard oncology care was
increased for all educational program attendees. Additionally scores reveal a favorable
shift for use of OET in conjunction with standard oncology care and patient participation
in clinical trials. By conducting educational programs with four oncology care provider
groups, relationships were established with all of the oncology care provider groups in
the project setting.
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Introduction
The National Center for Complementary and Alternative Medicine (NCCAM)
defines complementary and alternative medical (CAM) approaches as “a group of diverse
medical and health care systems, practices and products that are not generally considered
a part of conventional/allopathic medicine” (NCCAM, 2010). Complementary and
alternative (CAM) approaches are grouped into categories which include: (a) natural
products, (b) mind and body medicine, and (c) manipulative and body-based practices.
Data from the 2007 National Health Interview Survey (NHIS) reveals that adults in the
United States spent 33.9 billion out-of-pocket dollars on visits to CAM practitioners and
purchases of CAM products, classes and materials (Nahin, et al, 2009). Additionally the
2007 estimates place overall prevalence of CAM use at 38.3 percent (83 million) of
adults in the United States (Nahin, et al, 2009).
Patients seeking relief from the side effects of cancer therapy often turn to
approaches outside of the conventional medical model. The debilitating side effects of
radiation and chemotherapy, e.g. nausea/vomiting, sore mouth, loss of appetite, pain,
fatigue, hair loss, and numbness/tingling in fingers and toes, often are not adequately
managed with conventional medical approaches. A survey conducted with patients
receiving care at M.D. Anderson Cancer Treatment Center in Houston, Texas, revealed
CAM use was common in this patient population (Richardson, et al, 2000).
Use of CAM approaches in lieu of or in conjunction with conventional oncology
care appears to be absent in clinical oncology literature published in the United States.
Peer-reviewed articles from journals such as the American Journal of Clinical Oncology
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and the Oncology Nursing Forum center predominantly on managing standard oncology
care, such as radiation and chemotherapy.
Most CAM approaches use natural substances that are not proprietary and to date
have not been patented by the U.S. Patent Office. Research and development dollars are
not typically spent on CAM products or approaches. Clinical research on CAM
approaches is required for sustainability of their use in the current evidence-based
medical culture. Meanwhile clinical research on CAM approaches is requisite for
sustainability of their use in the current evidence-based medical culture. This poses a
dilemma regarding ways to generate evidence-based CAM approaches to treat the side
effects of cancer therapy but sets the stage for a well-designed clinical research trial to
evaluate the use of CAM approaches in conjunction with or in lieu of conventional
oncology care.
Additionally medical and nursing school curricula do not include course offerings
on the use of CAM approaches as treatment for health problems making their use in
practice challenging. Based on this lack of education, health care providers are
challenged to develop an in-depth understanding of CAM approaches. The challenge
must be met with the same scientific rigor and discipline that has successfully served the
biomedical model.
Extensive clinical experience has been gained by this doctoral student with
patients who use CAM approaches. In particular experience has been gained with
patients who use oral enzyme therapy (OET) in combination with their standard oncology
care. Observations of clinical outcomes for these patients reveal reduction in the
severity, and at times prevention, of many of the expected side effects associated with
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standard oncology care. Anecdotal observations regarding fatigue, pain, and
numbness/tingling of the hands and feet suggest a benefit for patients with cancer who
use OET in conjunction with their standard oncology care. Healing damaged skin
secondary to radiation therapy has been observed in patients who use OET.
An informal survey among a network of CAM practitioners who recommend OET
for their patients receiving chemotherapy or radiation therapy reveals similar anecdotal
observations to those cited above.
Yet anecdotal observations do not stand up to scrutiny in today’s evidence-based
health care culture and CAM approaches must be evaluated in a scientific manner using
well-designed clinical trials.
This Doctor of Nursing Practice Clinical Scholarship Project (CSP) is the first
step in beginning to quantify data about the effect of OET in a group of women with
breast cancer. The population of women with breast cancer is meaningful for two
different reasons. The first is personal since my sister died from recurrent, metastatic
breast cancer. The second is epidemiologic in that one in eight women will be diagnosed
with breast cancer over the course of her lifetime (ACS, 2010). The review of the
literature presented later in this paper reveals that the use of OET may prevent, reduce or
eliminate the side effects associated with standard oncology care. A reduction or even
prevention of the side effects associated with standard breast cancer chemotherapy
regimens may improve the quality of life for women with breast cancer. Preventing,
reducing or eliminating side effects may result in decreased cost of care for breast cancer
patients undergoing chemotherapy.
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Project Rationale
This doctoral student conducted a clinical scholarship project (CSP) regarding the
use of OET in conjunction with standard oncology care. The CSP aims to uncover the
strengths and weaknesses of a proposed venture to determine the interest from the
community regarding their involvement in a research study on the topic of OET. This
CSP allowed for identification of opportunities and threats presented by the
implementation of such a research study and the process of conducting such a research
study at some time in the future.
In Southwest Missouri there is a noticeable lack of use of complementary and
alternative medicine (CAM) approaches in health care practice. This fact suggests that
conventional health care providers are not recommending the use of OET. The proposed
CSP may enhance future efforts in conducting clinical research that includes OET.
Intent of the Clinical Scholarship Project
The major component of the proposed CSP was the development and
implementation of an educational program entitled “Enzyme Nutrition in Cancer Care”.
The educational program was presented to both oncology care providers and women with
breast cancer. Goals of presenting the educational program include: (a) increased
knowledge on use of OET to prevent/reduce the side effects of standard oncology care,
and (b) assessment of the attitude of oncology care providers and women with breast
cancer regarding OET use.
The intent of the proposed CSP was to evaluate outcomes of presenting “Enzyme
Nutrition in Cancer Care”. Several issues have been identified that may impact
implementation of OET in conjunction with standard oncology care. Those issues
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included: (a) observed lack of implementation of CAM approaches in the project region,
(b) an observed lack of knowledge among health care providers and the general public
regarding CAM approaches, and (c) the prevailing conventional medical culture. The
proposed CSP was designed to: (a) enhance the knowledge of oncology care providers
and women with breast cancer on use of OET in conjunction with standard oncology
care, (b) assess the attitudes of oncology care providers and women with breast cancer
regarding OET use, and (c) establish relationships with the oncology care community and
with groups for women with breast cancer.
Stakeholders Identified for the Clinical Scholarship Project
In Springfield, Missouri, there are two large oncology care groups. Oncology
Hematology Associates is affiliated with Cox Health Systems, and Hematology and
Oncology Clinics is affiliated with Mercy Medical Missions. Each health system has a
dedicated cancer resource center: C.H. “Chub” O’Reilly Cancer Center at Mercy Medical
Missions, and Hulston Cancer Center at Cox Health Systems. Each of these two large
health care systems in Springfield has a dedicated breast cancer center. Additionally the
feasibility project included Skaggs Cancer Center in Branson (approximately 35 miles
south of Springfield) and Central Care Cancer Center in Bolivar (approximately 40 miles
north of Springfield).
Another group includes members of each of the oncology care groups mentioned
above who joined forces for purposes of conducting clinical research. This joint venture
is known as the Cancer Research for the Ozarks (CRO). While their research efforts
focus on standard oncology care protocols, inclusion in the stakeholder discussion is
warranted as CRO faces challenges and barriers in conducting clinical research. This
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doctoral student anticipates similar challenges and barriers for conducting clinical
research on CAM approaches.
Additional stakeholders for this CSP included women with breast cancer who
attend support group meetings in the study setting. A cursory survey revealed two such
groups that are active at the time of project implementation.
Conceptual Framework
Mior, Barnsley, Boon, Ashbury and Haig (2010) designed a qualitative study
aimed at promoting interprofessional collaboration between physicians and chiropractors
in a community-based primary care setting in Ontario, Canada. The resultant framework
yielded processed-based factors that fell into three categories: (a) communication, (b)
practice parameters, and (c) service delivery (Mior, et al, 2010). The emergent
framework focused on patient care and attributes promoting a trusting relationship
between chiropractors (CAM providers) and physicians in a primary care community
setting.
Delineated in the framework are activities to enhance communication.
Attendance at formal meetings, which include regular educational programs to share
knowledge about relevant aspects of evidence-based patient care, is promoted. Case study
discussions are used as the educational format for facilitating discussion. Informal social
meetings are used for developing personal relationships and mutual trust and respect
(Mior, et al, 2010).
The conceptual framework developed by Mior, et al, (2010) may help promote
interprofessional collaboration not only between physicians and chiropractors, but also
between other health care providers. The conceptual framework developed by Mior, et
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al, (2010) was selected for the CSP and is appropriate for CAM providers to begin
establishing relationships with members of the conventional medical community and for
facilitating outcomes of the clinical scholarship project (see Figure 1).

Communication
Formal
Informal
Administrative Meetings
Education

Practice Parameters

Patient Care

Service Delivery

Philosophy

Access

Specialty Conditions

Affordability

Evidence-based Care

Reimbursement
Liability

Figure 1. Framework focusing on patient care and promoting collaboration (Mior,et al).
Review of the Literature
Literature on Enzyme Therapy in Oncology Care
Somewhat misunderstood, use of enzyme therapy struggles to gain a legitimate
position in medical approaches in the United States. There is limited literature on it in
peer-reviewed oncology journals. Yet the foundations of modern enzyme therapy can be
found in a book by an English physician, John Beard, DSc, published in 1911 entitled
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“The Enzyme Treatment of Cancer and its Scientific Basis” (Beard, 1911). Extending
early science on enzyme therapy came when James B. Sumner was awarded the Nobel
Prize in Chemistry for his efforts to crystallize the enzyme urease from jack bean meal
and identified it as a protein (Sumner, 1946; Zanker, 2001).
Plant extracts with high proteolytic enzyme activity have been used for a long
time in traditional medicine (Leipner & Saller, 2000). Therapeutic use of proteolytic
enzyme therapy is based partially on scientific studies and partially on empirical
evidence. Modern enzyme therapy often includes pancreatic enzymes. Clinical studies to
evaluate the efficacy of proteolytic enzyme therapy in oncology have mostly been
conducted with an enzyme preparation that contains both plant and pancreatic enzymes.
German researchers designed an epidemiological retrospective cohort analysis
with parallel groups to evaluate the impact of OET given complementary to standard
oncology care therapy in patients with all stages of colorectal cancer. In a cohort of 1242
patients with colorectal cancer, 616 received complementary treatment with OET while
626 had not received OET. Patients who had undergone primary surgery numbered
1162. For primary surgical patients, 526 received adjuvant chemotherapy and 218
received radiation therapy. Median follow-up time for the OE group was 9.2 months and
for the control group 6.1 months. The primary test criterion of efficacy for the OET
group was the multivariate effect size of the changes from baseline of the disease-related
and therapy-related signs and symptoms of nausea, vomiting, changes in appetite,
stomach pain or stomach disorder, tiredness, depression, memory or concentration
disorder, sleep disturbance, dizziness, irritability, dyspnea at rest, dyspnea during activity,
headache, tumor pain, cachexia, skin disorders and infections. Safety of OET was
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analyzed in terms of number and severity of adverse events, their duration, treatment and
outcome. Analysis revealed a significant reduction in disease-associated signs and
symptoms in patients treated with OET. Adverse reactions to chemotherapy and
radiation therapy were diminished in all patients receiving OET. Researchers concluded
that treatment of colorectal cancer patients with adjuvant OET reduces the signs and
symptoms associated with their disease process and reduces the adverse reactions
associated with adjuvant standard oncology care therapies (Popiela, et al, 2001).
Researchers in India conducted a prospective, randomized clinical trial enrolling
120 subjects undergoing radiation therapy for treatment of locally advanced, biopsy
proven carcinomas of the cervix (Stages IIa, IIb or IIIb). Patients received 50 Gy of
external radiation therapy over a period of 5 weeks, followed by intra-cavitary
brachytherapy of 20-30 Gy. Sixty patients who were assigned to the test group received
additional OET. Patients were evaluated weekly for acute radiation therapy-related side
effects and for an additional 8 weeks after the conclusion of their radiation treatment.
Results of the study revealed that the maximum extent of acute radiation side effects was
reduced in the enzyme group: a) skin reactions (mean 0.97 vs 1.68 in the control group,
P<0.001); b) vaginal mucosa reactions (mean 0.55 vs 0.85, P=0.10); c) genitourinary
symptoms (mean 0.93 vs 1.38, P<0.001); and d) gastrointestinal reactions (mean 1.12 vs
1.30, P=0.12). Sum scores during treatment were noted to be significantly less in the
enzyme treated patients. All observed side effects of radiation therapy were of lower
intensity in the enzyme group. Based on study findings the researchers concluded that
for patients with locally advanced cancer of the cervix, OET was found to be effective in
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significantly reducing radiation side effects such as genitourinary symptoms,
subcutaneous changes and reactions of the vaginal mucosa (Dale, et al, 2001).
In Germany an epidemiological, multicenter retrospective cohort study was
conducted to evaluate the impact of OET given complementary as a post-operative care
approach with breast cancer patients receiving standard anti-neoplastic therapy. A cohort
of 2339 breast cancer patients undergoing surgical intervention and radio, chemo- or
hormonal therapy were studied in 216 centers. Of the 2339 patients, 1283 received
complementary OET and 1056 patients did not. The median follow-up team for the test
group was 485 days and for the control group 213 days. The endpoint of the study was to
evaluate if complementary OET can reduce typical disease- or therapy-associated signs
and symptoms (e.g. gastrointestinal symptoms, mental symptoms, dyspnea, headache,
tumor pain, cachexia, skin disorders, infections and side effects associated with standard
oncology care protocols) in patients with breast cancer. Analysis of data revealed for all
symptoms, except tumor pain, the adjusted mean improvement in symptom scores was
larger in the test group than in the control group. The adjusted difference was statistically
significant for all symptoms except tumor pain and infections. Results demonstrate that
the typical disease- and therapy-associated signs and symptoms for breast cancer patients
on complementary OET during postoperative treatment were significantly less (Beuth, et
al, 2001).
Patients with invasive breast cancer receiving adjuvant or palliative chemotherapy
between 2005 and 2006 who had at least two further cycles of chemotherapy scheduled
were studied by researchers in Austria. The hypothesis was that specific toxicities of
individual patients would be reduced by the use of OET. The majority of the 57
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consecutive patients received palliative chemotherapy. Researchers concluded that OET
administered consistent with the study protocol had only a marginal influence in patients
with breast cancer who had experienced grade two toxicity in the preceding cycle and
who had received two additional identical cycles of chemotherapy (Petru, et al, 2010).
Researchers in the Slovak Republic utilized OET adjunctively with standard
combination chemotherapy for patients with multiple myeloma. A cohort of 265 patients
with multiple myeloma stages I-III was treated consecutively in two parallel groups. An
OET regimen was given to 166 patients receiving standard chemotherapy while 99
patients receiving standard chemotherapy served as the control group. Primary endpoint
for this study was disease-specific survival. Secondary endpoints were response to
therapy, duration of the first response and side effects. Survival analysis was performed
using the Kaplan-Meier method and a multivariate analysis was done with the Cox
proportional hazards model. Analysis revealed significantly higher overall response rates
and longer duration of remissions for the OET group. Additive therapy with OET for
greater than six month duration decreased the hazard of death for patients at all stages of
disease by approximately 60 percent. Observation time was not adequate to estimate the
median survival for patients with Stage I and Stage II disease; for Stage III patients
median survival was 47 months in the control group versus 83 months in the OET group
(Sakalova, et al, 2001). Based on these findings, a prospective, randomized Phase III
study was initiated in the United States under an orphan drug designation. A search
regarding the outcome of the aforementioned Phase III study entitled “Chemotherapy
With or Without Wobe-Mugos E in Treating Patients with Stage II or III Multiple
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Myeloma” [protocol ID MUCOS-MU 699-501, NCT 00014339] reveals recruitment has
closed but final results are not available.
Discussion
Review of this limited scientific literature supports use of OET in conjunction
with standard oncology care as a safe and efficacious approach for the prevention or
reduction of side effects observed from such therapy. Observation of conventional
oncology care approaches in the United States reveals use of OET is not commonplace.
A potential explanation includes a lack of knowledge of oncology care providers with
regard to OET. A lack of prospective, randomized, controlled clinical trials on the use of
OET in the United States may be another factor.
Review of the Literature on Continuing Education Programs
A review of the literature supports the use of an educational program for
achieving the ultimate aim of this clinical scholarship project. Studies show that
educational programs impact both knowledge and attitudes for both health care providers
and patients. Studies cited below demonstrate the impact of educational programs
presented to both provider and patient audiences.
Researchers conducted a study to evaluate the impact of a continuing education
course on general practitioner knowledge, attitude, practice approach and patient
outcomes with regard to the diagnoses of depression and anxiety. A case controlled
before-and-after design was used with fourteen general practitioners who participated in
the continuing education program. Practitioners who participated in the educational
program were matched with fourteen general practitioners who did not participate.
Differences between the groups and pre- and post-test measurement of knowledge,
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attitude and clinical practice were examined using t-tests and chi-square tests for
categorical variables and analysis of covariance for continuous variables. Analysis of the
data resulted in statistically significant changes in the intervention group of general
practitioner’s knowledge and attitude regarding the diagnoses of depression and anxiety.
Findings reveal attendance at a continuing education program can result in a change in
practitioner knowledge and attitudes (McCall, Clarke, and Rowley, 2004).
A randomized controlled trial (RCT) was conducted to investigate the
effectiveness of, and satisfaction with, small-group problem-based learning (PBL) versus
a didactic lecture approach for disseminating evidence-based guidelines on asthma
management. Both groups experienced a significant increase in asthma related
knowledge. However PBL participants rated the perceived educational value of the
program higher than did lecture participants (4.36 vs 3.93, P=.04) suggesting a more
satisfactory learning experience. Small group sessions, such as the PBL sessions used for
this study, with participants sitting around a conference table may be preferable for
disseminating clinical information to providers in the context of busy schedules and
multiple responsibilities (White, et al, 2004).
Investigators sought to evaluate the effectiveness of a community based cervical
cancer education program targeting both nurses and women living in rural areas of
Honduras. Radio programs were used to deliver the education program to the general
public. There were short spot messages that aired at fifteen or thirty minute intervals and
an hour long message that aired twice a day. At the nurses’ monthly educational session
a forty-five minute education program was presented. Structured interviews were used to
evaluate the knowledge level regarding the need for screening pap smears among women
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in the community before and after the radio broadcasts. Response score increases were
statistically significant for all knowledge categories evaluated for the women in the
community who had attended the educational program via radio broadcasts. Pre- and
post-intervention questionnaires were administered to the nurses. Statistically significant
differences were observed in all knowledge categories evaluated for the nurses who
attended the program. Researchers concluded that in developing countries, inexpensive
community-based educational programs delivered via radio broadcasts and lecture
presentations can increase cervical cancer knowledge and impact health care behavior
(Perkins, et al, 2007).
A study was conducted to evaluate the effectiveness of a nurse-initiated education
program on osteoporosis prevention behaviors. A randomized controlled study was
conducted with seventy-six women. A forty-five minute educational program on the four
osteoporosis prevention behaviors was conducted with the thirty-eight women
randomized into the intervention group. Two follow-up phone consultations were
conducted within the month following the program. Pre-, post- and follow-up data were
compared regarding attitudes and adoption of osteoporosis behaviors. Results of analysis
revealed statistically significant increases for adoption of each of the behaviors by the
intervention group when compared to the control group (Chan and Ko, 2006).
Discussion
Central to the CSP design is to present an educational program to members of the
oncology care community and to women with breast cancer. Using this approach is well
supported based on review of the literature and consistent with the conceptual framework
described by Mior, et al, (2010). Continuing education programs delivered in a fashion
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similar to the proposed program have been shown to have an impact on the knowledge
and attitudes of both health care providers and the general public. Impact on attitudes
and enhanced knowledge regarding the use of OET in conjunction with standard
oncology care may benefit future clinical research efforts.
The Educational Program
An educational program entitled “Enzyme Nutrition in Oncology Care” regarding
the use of enzyme therapy in oncology care was developed (see Appendix A) and
implemented to facilitate the stated aim of this clinical scholarship project. Topics
covered in the educational program include: (a) an overview of enzyme therapy, (b) the
history of enzyme therapy use in oncology care, (c) review of the science regarding
enzyme therapy used in conjunction with standard oncology care protocols, and (d)
presentation of anecdotal observations regarding the use of OET with oncology patients.
A Power- point presentation format was used to aid presenting the educational
program. The same program was used with both oncology care provider groups and
groups of women with breast cancer, their support persons and the general public. While
the program was the same, during the presentation emphasis was placed on different
aspects tailored to the target audience. The physiology and biochemistry of proteolytic
enzymes was emphasized for provider groups while clinical experiences with OET were
emphasized for women with breast cancer, their support persons, and the general public.
Evaluating effectiveness of the educational program was accomplished by use of
a pre-test/post-test design. A multiple item knowledge test, containing multiple choice
and true/false items, was developed to measure clinical knowledge about basic
physiologic enzyme activity and the role of enzyme nutrition in oncology care (see
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Appendix B). The test was administered to participants prior to the educational program
and again at the conclusion of the program; in a pre-test/post-test design. Participant pretest/post-test scores were compared as a way of evaluating the effectiveness of the
educational program.
Provider attitude and behavior was measured using a student-developed
questionnaire specific to this clinical scholarship project (see Appendix C). The
questionnaire contains one yes/no item and three Likert-scaled items. The questionnaire
was administered in a pre-and post-program fashion. Provider responses completed prior
to the educational program are compared with their responses completed after the
educational program. Changes in provider attitude and clinical approach with regard to
OET were evaluated by comparing these responses. Provider willingness to support
patient participation in a clinical research study using OET with standard oncology care
was assessed as well.
Attitude and behavior of women with breast cancer, their support persons, and the
general public were measured with a student-developed questionnaire using the same
process used for the provider groups. The questionnaire contains one yes/no item and
three Likert-scaled items (see Appendix D). A change in attitude and stated care
approach with regard to OET for women with breast cancer, their support persons, or the
general public were evaluated by comparing responses on the pre-program questionnaire
with those on the post-program questionnaire. Willingness to participate in a clinical
research study using OET with standard oncology care was assessed as well.
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IRB and HIPPA Issues
The proposed clinical scholarship project included implementation of an
educational program on the use of OET in conjunction with standard oncology care. A
knowledge test and an enzyme use questionnaire were used as a part of the educational
program. No personal identifying information or health care information was collected
during the project. An IRB submission for exempt approval was initiated by this doctoral
student and an exemption was granted in accordance with Title 5 Code of Federal
Regulations Part 46.101b. There are no identifiable HIPPA issues, given that no personal
identifiers are used and no protected health information was collected from attendees.
Setting and Participants
The setting for this feasibility project was the greater Springfield, Missouri, the
location of this doctoral student’s clinical practice. Springfield’s population is
approximately 200,000 people. A brief telephone survey conducted with the two large
health care facilities in Springfield revealed an average of 600 – 650 women newly
diagnosed with breast cancer annually. The project setting was expanded to include
Branson, Missouri and Bolivar, Missouri, both of which are approximately forty miles
outside of Springfield. Presence of a designated cancer center in these communities
makes their inclusion in the feasibility project appropriate. A brief telephone survey
conducted with Bolivar revealed an average of 30-35 newly diagnosed women with
breast cancer annually and telephone survey results for Branson revealed a similar
number of women diagnosed with breast cancer annually.
Potential participants for the project’s educational program included any of the
oncology care providers in the project setting and women with breast cancer, their
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support persons, or the general public. Staff members of local breast cancer screening
programs, breast cancer support groups, breast cancer advocacy groups, and the
American Cancer Society local office are also potential participants. While the latter
group are not typically involved in clinical decision making regarding treatment they are
included in this project because they provide support to women diagnosed with breast
cancer.
Implementation Activities
Activities to move the project forward to completion commenced upon receiving
approval for the proposed CSP by this doctoral student’s committee. After IRB review
and approval implementation activities were launched. The main activities included: (a)
identifying resources used by women with breast cancer in the project setting, (b)
identifying educational resources used by women with breast cancer in the project
setting, (c) identifying group or meeting resources utilized by women with breast cancer
in the project setting, (d) determining the ability to interface with women with breast
cancer as a part of/during group or meeting formats, (e) determining availability of
facilities to conduct the proposed educational program with women with breast cancer,
(f) identifying educational resources used by oncology care providers in the project
setting, (g) determining the ability to interface with oncology care providers in the project
setting, (h) identifying appropriate facility use to conduct the educational program with
oncology care providers, (i) disseminating information about the scheduled educational
programs for women with breast cancer, (j) conducting the proposed educational program
with women with breast cancer, their support persons and the general public, (k)
disseminating information about the scheduled educational programs for oncology care
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providers, and (l) conducting the proposed educational program with oncology care
providers.
Identifying resources used by women with breast cancer in the project
setting – to include general resources, educational resources and support group
resources. Face-to-face, phone, and internet inquiries were conducted in the project area
regarding the resources available to/used by women with breast cancer. There is a cancer
resource center at the Hulston Cancer Center located in a building on the Cox Health
System campus. Individuals with cancer in the project setting, including women with
breast cancer, can browse through the resource center and find information about groups,
meetings and support services. There is a general retail store located in this center with
products that may be of interest and benefit to individuals undergoing standard oncology
care, e.g. hats, scarves, special garments, or items to be of assistance to caregivers e.g.
personal hygiene assistance devices, safety devices. Also found in this resource center is
a wide variety of reading materials/books on the subject of dealing with cancer. A
monthly calendar of support and group meetings can be found on the information desk in
the resource center.
Typically on the third Thursday of the month there is a breast cancer support
group meeting held in the evening at the Hulston Cancer Center. However, with October
being breast cancer awareness month, the Pink Ribbon Rally and Luncheon for Breast
Cancer was held on October 22nd instead of the usual support group meeting.
Informational flyers with dates, times and locations of the OET educational program
were handed out at this event.
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Extensive networking and investigation revealed that there are no other breast
cancer support groups meeting in the project setting at the present time. The Breast
Cancer Foundation of the Ozarks sponsors a Young Survivors group in Texas County,
Missouri. However a phone conversation with the coordinator of this program revealed
that active group meetings that had taken place for about the last year.
Contact with the American Cancer Society (ACS) office in the project setting
revealed that they do not sponsor any support group activities for breast cancer patients.
However the local ACS does sponsor the Reach to Recovery Program. The Reach to
Recovery Program was implemented to assist individuals diagnosed with breast cancer
navigate the diagnosis and treatment. The program pairs a trained volunteer who is a
breast cancer survivor in a one-on-one relationship with a woman who is newly
diagnosed with breast cancer. Conversations with ACS staff members revealed that a full
day Reach for Recovery Program training class was scheduled for October 29, 2011. A
request was made by this doctoral student to be able to attend the training course as an
observer. This request was denied.
Determining the ability to interface with women with breast cancer and
availability of facilities to conduct the educational program with them. Lack of
consistent group and support meetings for women with breast cancer in the project setting
resulted in then need to expand activities for successful implementation of the
educational program. Facilities in the project setting appropriate for conducting the
educational program were surveyed in regard to availability and costs. After extensive
surveying it was determined that the most acceptable settings, based on availability,
accessibility, and cost were community rooms at the local public libraries.
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For the public libraries in Springfield and Bolivar, Missouri, use of community
rooms was restricted to not-for-profit activities. Even though presentation of the
educational program was a not-for-profit venture, scheduling of rooms at the libraries
could not be accomplished without a not-for-profit organization sponsoring the proposed
educational program. A not-for-profit health ministry, High Way Ministries, founded by
this doctoral student in 2003 became the sponsoring organization for the proposed
educational program.
Identifying educational resources used by oncology care providers. Phone
contact was made with oncology care provider groups in the project setting. Practice
managers and/or advanced practitioners from each of the groups were queried as to the
continuing educational approaches used most often for dissemination of information
regarding patient care approaches. This inquiry revealed that a common approach used
across multiple practice settings was a breakfast or lunch presentation in the office.
Other approaches included attendance at grand rounds, journal review/journal club
activities and attendance at continuing education programs.
Determining the ability to interface with oncology care providers and
availability of facilities to conduct the educational program with them.

Contact was

made with each of the oncology care provider groups mentioned in this document as
stakeholders with the exception of CRO, as members there were represented in other
stakeholder groups. Another contact was made with the American Cancer Society Office
in the project setting.
An educational program was conducted with each of the stakeholders with the
exception of the ACS, whose administrative representative declined the invitation to
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participate in the project. All of the oncology provider groups determined that the best
setting to conduct the educational program was in the oncology clinic or oncology
infusion center so as to minimize the disruption of the work flow of the providers who
might possibly attend the program.
Disseminating information about the scheduled educational programs for
women with breast cancer. Implementation of the CSP was planned to coincide with
national breast cancer awareness month. It was discovered that the Breast Cancer
Foundation of the Ozarks was sponsoring and promoting “Breastfest” on October 1st.
Event activities included mini-educational programs on topics related to the experience of
breast cancer. Several health and wellness organizations in the project setting served as
both vendors and presenters. The event was attended with the express purpose of
distributing flyers to event vendors and attendees with dates, times and locations that the
OET educational program was going to be held for women with breast cancer, their
support persons, and the general public. Nearly fifty flyers were distributed at this event.
Community resources that offered avenues to announce/promote the educational
program were explored. It was determined that three local publications had a community
announcement service available that would allow publishing, at no cost, information
about the educational program to include the following: (1) dates, times and locations of
presentations, (2) a brief description of information that would be presented, and (3) the
sponsoring organization for the presentations. As noted earlier in this document, use of
community rooms at local public libraries required that the presentations be sponsored by
a not-for-profit organization and they required that all flyers and postings contain the
name of the sponsoring organization. Announcements were placed in the available
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community publication resources three weeks in advance of scheduled presentations of
the educational program. Flyers were placed on community boards at local health food
stores, specialty book stores, and organic markets.
Conducting the educational program with women with breast cancer, their
support persons and the general public. Eight sessions were scheduled in which to
present the educational program to women with breast cancer, their support persons and
the general public. Programs were presented in community rooms at public libraries in
the project setting. Programs were conducted in Bolivar, Springfield and Branson.
Attendance at the programs varied from location to location. Larger attendance was
observed at programs held in Springfield where the general population is about six times
the population of each of the two smaller municipalities.
Presentation of the educational program varied from approximately forty minutes
to sixty minutes. The longer times were observed in programs with the larger attendance
numbers as there was more discussion during the presentation. A question and answer
session was conducted at the conclusion of each program which lasted as long as
necessary to insure all questions had been adequately addressed.
Disseminating information about the scheduled educational programs for
oncology care providers. Reliance on administrative staff members of the oncology
care provider groups was the vehicle used to disseminate dates and times for presentation
of the continuing education program to the oncology providers. Avenues reported to
have been used included: (a) break room bulletin/announcement boards, (b) flyers posted
on entry/exit doors, (c) flyers posted in restrooms, (d) flyers placed in staff internal
mailboxes, and (e) intra and inter-departmental email communications.
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Conducting the educational program with oncology care providers. A total of
four presentations of the educational program were scheduled. Each of the oncology care
provider groups had conference rooms in or near the clinical services area making it
convenient for providers to attend the educational program. Presentation of the
educational program varied from approximately thirty minutes to forty minutes. A
question and answer session was conducted at the conclusion of each program which
lasted as long as necessary to insure all questions had been adequately addressed.
Deviations from Proposed Plan and Rationale
The original project design was to conduct the educational program with
oncology care provider groups and women with breast cancer. Project implementation
activities quickly revealed the lack of routine/recurrent gatherings of women with breast
cancer. The decision to launch study activities during national breast cancer awareness
month did lead to the ability to market the proposed program to women with breast
cancer. However it was determined that attendance at the educational programs would
have to be open to support persons of women with breast cancer and the general public in
order to make the activity a meaningful one, thus reaching a wider audience. This was
not part of the original design but the inclusion of these additional individuals in no way
altered the educational program. Presenting the educational program to the wider
audience may potentially have a greater impact on knowledge of OET in the study
setting. In retrospect, it would have been logical to include support persons of women
with breast cancer as a part of the original target audience. Often these individuals are
the guiding force for women with breast cancer who navigate complex treatment
modalities.
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Barriers and Challenges
Based on observed lack of implementation of CAM approaches by oncology care
providers in the project setting, lack of support for implementation of same in
conjunction with standard oncology care was anticipated. Such lack of support could
have an adverse effect on implementation of the clinical scholarship project. Initial
inquiry regarding scheduling of the educational program was received with responses
such as: (a) not sure the providers will have time, (b) don’t think the providers will be
interested in an education program on the use of enzyme nutrition, and (c) not sure the
providers would be in favor of patients taking any supplements during their course of
standard oncology therapy. Permission to conduct the educational program was obtained
only after introducing the topic of the possibility of a funded research study in the future.
Once the topic of potential clinical research was introduced greater receptivity was
observed. The ability to schedule the educational program with oncology care provider
groups suggests partially overcoming the anticipated barrier that the prevailing
conventional medical culture may adversely affect implementation of the proposed
feasibility project.
The challenge of time was not anticipated to be such a barrier when designing the
project. In the oncology care provider groups, the individual scheduling the educational
program was mindful about the amount of time involved for the educational activity. The
scheduler wanted to insure that there would be no inconvenience to the personal
schedules of the providers and that there would be no negative impact on delivery of
patient care services. This challenge was overcome by scheduling the oncology care
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provider programs early in the morning when providers would typically be arriving at the
clinical site and just prior to beginning of patient care activities.
Conducting the educational program took, on average, fifty minutes when
presented to the public audience, the provider programs needed to be streamlined for
delivery in thirty minutes. Accomplishing this task was facilitated by the fact that the
educational preparation of providers was such that the language and physiologic concepts
were not foreign and did not require in depth explanation. This allowed for progression
through aspects of the program at a much faster pace than for the general public. That is
not to say that questions that arose from providers were not adequately addressed; in fact
they were addressed as they arose during the presentation. However more questions
arose from the general public attendees regarding the physiologic concepts presented
during the program.
Clinical Scholarship Project Outcomes
Analysis of Data
As outlined in the Educational Program Section of this paper, enzyme knowledge
tests and enzyme use questionnaires were administered prior to the educational program
and then again after the program. Pre-program enzyme use questionnaire responses and
enzyme knowledge test scores were compared to the post-program responses and scores.
Discussion is summarized separately for the general public and the oncology care
providers. Table 1 presents a summary of the results for general public participants and
Table 2 presents a summary of the results for oncology care provider participants.
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Table 1: General Public Participants (N=36)

% of Participants

Knowledge test - total increased scores from pre-test to post-test

69%*

Use Questionnaire # 2: selected a higher number on the post-program survey
for the Likert-scale response question with regard to their likelihood of taking
OET along with chemotherapy

40%**

Use Questionnaire # 3: selected a lower number on the post-program Likertscale response question with regard to their likelihood of stopping OET if
their health care provider recommended they do so

40%**

Use Questionnaire # 4: selected a higher response on the post-program Likertscale response question with regard to their likelihood of participating in a
research study where OET was used in conjunction with standard
chemotherapy

40%**

*31% of general public participants scored 100% on the pre-test, resulting in no change between pre-test and
post-test scores
**46% of general public participants did not demonstrate a change because their initial responses were in the
affirmative

For the general public enzyme knowledge test, analysis of pre-test/post-test scores
reveals increased scores for 69% of participants. It should be noted that the remaining
31% of general public attendees scored 100% on the pre-test so there was no change in
post-test scores. Based on these findings the educational program was effective in
increasing the general public attendees’ knowledge of the use of OET.
The enzyme use survey administered in a pre-program/post-program fashion was
used to evaluate if the educational program could impact participant’s attitudes regarding
use of OET in conjunction with oncology care protocols. Analysis of the responses on
the pre-test survey revealed that 23% of participants were already taking OET. Analysis
of the remaining data will not include data from these participants as their current use of
OET is demonstrative of their attitude with regard to its use. Comparison of the data with
respect to the remaining participants reveals the following: (a) 40% selected a higher
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number on the post-program survey for the Likert-scale response question with regard to
their likelihood of taking OET along with chemotherapy, (b) 40% selected a lower
number on the post-program Likert-scale response question with regard to their
likelihood of stopping OET if their health care provider recommended they do so, and (c)
40% of participants selected a higher response on the post-program Likert-scale response
question with regard to their likelihood of participating in a research study where OET
was used in conjunction with standard chemotherapy. These responses suggest the
educational program impacted the attitude of participants with regard to OET.
It should be noted that 46% of participants did not demonstrate a change on the
three enzyme use survey Likert-scale questions as their initial responses were at the end
of the scale demonstrating an affirmative attitude regarding: (a) use of OET in
conjunction with standard chemotherapy, (b) not stopping OET use with chemotherapy if
their health care provider advised them to do so, (c) and opting to participate in a research
study where OET was used in conjunction with standard chemotherapy.
Table 2: Oncology Care Provider Participants (N=32)

% of Participants

Knowledge test - total increased scores from pre-test to post-test

100%

Use Questionnaire # 2: selected a higher number on the post-program survey
for the Likert-scale response question with regard to their likelihood of
recommending the use of OET with chemotherapy

90%

Use Questionnaire # 3: selected a higher number on the post-program Likertscale response question with regard to their likelihood of not advising a
patient to discontinue OET in conjunction with chemotherapy

70%

Use Questionnaire #4:selected a higher response on the post-program Likertscale response question with regard to their likelihood of supporting a
patient’s participation in a research study where OET was used in conjunction
with standard chemotherapy

80%
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For the oncology care provider enzyme knowledge test, analysis of pre-test/posttest scores reveals increased scores for 100% of participants. Based on these findings the
educational program was effective in increasing the oncology care providers’ knowledge
of the use of OET. Unlike analysis of the general public knowledge test results, no
oncology care provider scored 100% on the pre-test. A possible explanation for this
phenomenon is that general public attendees self-selected to attend an education program
on a CAM modality as they have sought or are seeking solutions to health care problems
outside of the conventional medical approach.
The enzyme use survey administered in a pre-program/post-program fashion was
used to evaluate if the educational program could impact participant’s attitudes regarding
use of OET in conjunction with standard oncology care protocols. Analysis of the
responses on the pre-test survey revealed that 0% of the oncology care providers were
already discussing the use of OET in conjunction with standard oncology care
approaches. Analysis of the data with respect to oncology care providers’ responses
reveals the following: (a) 90% selected a higher number on the post-program survey for
the Likert-scale response question with regard to their likelihood of recommending the
use of OET with chemotherapy, (b) 70% selected a higher number on the post-program
Likert-scale response question with regard to their likelihood of not advising a patient to
discontinue OET in conjunction with chemotherapy, and (c) 80% of participants selected
a higher response on the post-program Likert-scale response question with regard to their
likelihood of supporting a patient’s participation in a research study where OET was used
in conjunction with standard chemotherapy. These responses suggest the educational
program positively impacted the attitude of oncology care providers with regard to OET.
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Discussion of Findings
In order to adequately discuss the findings cited above, a review of the
anticipated outcomes for the feasibility project is presented below:
Short Term Outcomes.
° Increase awareness of the scientific body of knowledge regarding use of oral
enzyme therapy in conjunction with oncology care.
° Increase oncology care provider and women with breast cancer’s knowledge of
oral enzyme therapy use in conjunction with standard oncology care.
° Initiate networking activities with oncology care providers and groups of women
with breast cancer.
Intermediate Outcome.
° Establishment of relationships with providers in the oncology care
community and groups of women with breast cancer by overcoming anticipated
and identified barriers.
Long Term Outcome.
° Improve the quality of life of women with breast cancer by maximizing the
relationships developed through this feasibility project which may facilitate
implementation of a clinical research study using OET in conjunction with
standard breast cancer chemotherapy.
Short term outcomes. Review of the change in scores from pre-test to post-test
administration of the enzyme knowledge test demonstrates that the short term outcome
was met. The enzyme knowledge test encompassed information gleaned from the
scientific body of knowledge regarding use of OET alone or in conjunction with standard
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oncology care. Questions and conversations that took place in conjunction with
presenting the educational program demonstrate increased awareness of OET in addition
to the increased knowledge demonstrated by testing. These evaluations and observations
hold for both the oncology care provider groups and group that included women with
breast cancer, their support persons, and the general public.
As previously described, networking activities were central to the successful
implementation of the clinical scholarship project. Networking activities were conducted
with oncology care provider groups and groups of women with breast cancer. However
networking activities with women with breast cancer did not take place in the context and
setting as anticipated.
Intermediate outcome. A challenge existed for establishing relationships with
groups of women with breast cancer. Group meetings thought to be in existence based on
initial assessment of resources in the project setting were discovered to be for the most
part inactive. The one support group that would typically have met during the most time
intensive period of project implementation altered their group meeting format for
alternate breast cancer awareness activities.
Long term outcome. The length of time for project implementation and
evaluation does not allow for evaluation of the stated long term outcome. Expanding
upon and nurturing of the relationships established with the oncology care provider
community during project implementation may prove to facilitate the desired long term
outcome. Additional requirement for achievement of the long term outcome would
include a funding source for a clinical research study to evaluate the use of OET in
conjunction with standard oncology care.
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Cost to Benefit Analysis and Ethical Concerns
Cost for implementing the clinical scholarship project included: (a) costs of
printed materials, writing instruments, and miscellaneous office materials for organizing
study documents; (b) cost of laptop computer and video projector to conduct the
education program; and (c) cost of light refreshments for program participants. It is
difficult to conduct an actual cost/benefit analysis regarding this CSP since the project
did employ some minimal costs yet the benefit of an educational program is not able to
be determined in such a small project.
One of the issues examined in this clinical scholarship project was the
establishment of relationships between this doctoral student and the oncology care
provider community. There was no relationship evaluation tool or instrument selected
for use as a part of this project, making it impossible to analyze data to come to a
conclusion for this question. Personal observation and reflection regarding the stated
question reveals: (a) use of a CAM approach, specifically OET, in conjunction with
standard oncology care for prevention/reduction of side effects was favorably received
and (b) this doctoral student, as a CAM provider, was favorably received by the members
of the provider community as well as the public. In the project setting’s conventional
medical culture, these observations are priceless.
Ethical concerns surrounding implementation of the project included the potential
lack of concern by conventional medical providers for women with breast cancer. That
concern was based on the observed lack of implementation in the project setting of CAM
approaches that have evidence-based efficacy. Implementation and evaluation of the
clinical scholarship project does not allow for an opinion or a conclusion to be formulated
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with regard to this ethical concern. Only case reviews and time will allow for evaluation
of the impact of this feasibility project with regard to the ethical concerns in the project
setting.
Application to Practice
As previously stated, implementation of the CSP will not result in any change in
clinical practice for this doctoral student. Protocols using OET are presently in use in this
doctoral student’s practice setting. Findings of this clinical scholarship project indicate
an increased knowledge base and a change in oncology care provider attitudes
surrounding the use of OET with cancer patients. Additionally implementation of the
CSP launched relationship building between the oncology care community and this
doctoral student. Perhaps a result of this relationship building will facilitate
implementation of clinical research using OET in conjunction with standard oncology
care. Furthering the science on use of OET in conjunction with standard oncology care
here in the United States may result in better quality of life for women with breast cancer
by prevention, reduction, or elimination of the side effects of chemotherapy.
While the focus population of this project was women with breast cancer, benefits
of OET in conjunction with standard oncology care have been observed with a wide
range of cancer types and therapies. Future projects may focus on the use of OET with
individuals diagnosed with other types of cancer. A project design focused on women
with breast cancer, implementing of the project to coincide with national breast cancer
awareness month, and establishment of relationships with the oncology care community
may enhance this doctoral student’s ability to co-manage oncology patients and conduct
clinical research.
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The application of findings of this CSP outside of the project setting is not
anticipated. The project was designed, implemented and evaluated specifically for a
given oncology care community. Perhaps the application of this project to nursing
practice will be forthcoming in the form of publications that may stem from designing,
implementing, and evaluating this clinical scholarship project.
Impact of the Clinical Scholarship Project on Evaluation of the DNP Role
A case can be made for representation of some aspect of each of the eight
Essentials of Doctoral Education for Advanced Nursing Practice by designing,
implementing, and evaluating the feasibility project. However a stronger correlation of
project activities to four of the essentials is observed. The discussion that follows will
explore those corollaries.
A review of the essentials of doctoral education for advanced nursing practice
reveals that development of this project is grounded in the first essential: scientific
underpinnings for practice. According to AACN (2006), to achieve the highest level of
nursing practice the DNP program prepares the graduate to integrate nursing science with
knowledge from ethics, the biophysical, psychological, analytical, and organizational
sciences. Exploration of literature from the organizational sciences ultimately facilitated
successful design, implementation and evaluation of this clinical scholarship project
(Asprey, 2004). Concepts of a pilot study to determine if such a project is feasible are
found in the nursing literature (Polit & Beck, 2004, Zust, 2000).
The ultimate goal of this CSP was to facilitate the conduct of future clinical work.
Future clinical work would be linked directly to the third essential: clinical scholarship
and analytical methods for evidenced-based practice. With respect to this essential, a
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correlation cannot be made between conducting this CSP and the tasks that AACN
delineates for the graduate of a DNP program since. Correlation cannot be made as this
doctoral student finds the seven tasks outlined for this essential limit the role of an
advanced practice nurse.
Given the wide range of provider types represented in the oncology care
community this project encompasses the sixth essential: interprofessional collaboration
for improving patient and population health outcomes. According to AACN (2006), the
DNP program prepares the graduate to use leadership skills with both intraprofessional
and interprofessional teams to create change in health care. Conducting the clinical
scholarship project resulted in development of interprofessional relationships. The
primary object of establishing such relationships is to enhance patient care outcomes and
when possible by the addition of CAM approaches with standard oncology care.
Developing, implementing and evaluating this project serves as the hallmark of
the eighth essential: advanced nursing practice. Of the seven tasks delineated for this
essential, conducting the feasibility project most closely relates to the second task:
design, implement, and evaluate therapeutic interventions based on nursing and other
sciences. Undertaking the clinical scholarship project is the first step on the journey to
enhance patient outcomes by implementing a CAM approach proven to prevent, reduce
or eliminate the side effects of standard oncology care.
Influence on Practice
The culmination of this doctor of nursing practice education is the further shoring
up of a solid clinical foundation for delivery of advanced practice activities. The
experience of the clinical scholarship project allowed this doctoral student to make
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inroads into a community of providers that often consider CAM providers as outsiders.
Relational foundation and a view of collegiality can only stand to accelerate the goal of
conducting clinical research studies on the use of CAM approaches in conjunction with
standard oncology care. More importantly, relationships established with members of the
oncology care community have paved the way for greater acceptance of CAM approach
use by patients with cancer. Such action may have a positive impact on patient outcomes
which is the ultimate goal of the healing arts.
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Appendices

A. Enzyme Therapy Educational Program Outline
B. Enzyme Knowledge Test
C. Provider Enzyme Survey
D. Enzyme Use Survey
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Appendix A
Oral Enzyme Therapy Educational Program Outline
1. Introduction

2. Pre-test/Survey (unique identifier – middle initial and house number – with a capital A)

3. Overview of enzyme therapy - a nutritional therapy
a)

role of enzymes in the body
i. role of enzymes in the digestive system (demonstration with food)
ii. role of enzymes in the immune system
iii. role of enzymes in the body

b) historical overview of enzyme use in cancer care

4. Overview of the Literature
a)

study 1 – OET, colorectal cancer

b)

study 2 – OET, cervical cancer

c)

study 3 – OET, breast cancer

d) study 4 – OET, breast cancer
e) study 5 – OET, multiple myeloma (emphasis on remission and survivability)

5. Anecdotal observations, questions and answers
a)

case study examples – breast cancer (pain, energy, wound healing, anemia)

6. Post-test/Survey (unique identifier – middle initial and house number – with capital B)
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Appendix B
Enzyme Knowledge Test
Identifier:_________________

Location:_________________

Please answer the following questions (place a check mark on the line next to your answer):
1. Digestive dysfunction is a risk factor for cancer.
___ True
___ False
2. Which of the following are actions of proteolytic enzymes?
___ A. reduce tumor size
___ B. digest proteins
___ C. decrease inflammation
___ D. reduce the toxic effects of chemotherapy and radiation
___ E. prevent metastasis (spread of cancer)
___ F. facilitate detoxification
3. Enzymes taken by mouth are destroyed in the stomach by hydrochloric acid.
___ True
___ False
4. Protein is used in which of the following physiologic activities?
___ A. energy
___ B. growth and repair
___ C. maintenance of homeostasis
5. Use of enzyme therapy can increase survivability for cancer patients?
___ True
___ False
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Appendix C
Provider Enzyme Questionnaire
Identifier:_________________

Location:_________________

Please answer the following questions (place a check mark or circle your answer):
1. Do you presently discuss the use of oral enzyme therapy with patients receiving
chemotherapy?
___ Yes
___ No
If the answer to #1 above is No, please answer questions below – thank you.
2. With your current knowledge regarding oral enzyme therapy, what is the likelihood that you
would recommend oral enzyme therapy to your patients receiving chemotherapy?
0
1
Would Not
Recommend

2

3

4

5

6

7

8

9

10
Would
Recommend

3. With your current knowledge regarding oral enzyme therapy, if a patient reported using oral
enzyme therapy along with their chemotherapy would you advise them to stop taking them?
0

1

2

3

4

5

6

7

8

Would Advise
To Stop

9

10

Would Not
Advise To Stop

4. With your current knowledge regarding oral enzyme therapy, what is the likelihood that you
would support your patient participating in a research study using oral enzyme therapy
adjunctively with chemotherapy?
0
Would Not
Support

1

2

3

4

5

6

7

8

9

10
Would
Support
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Appendix D
Enzyme Use Questionnaire
Identifier:_________________

Location:_________________

Please answer the following questions (place a check mark or circle your answer):

1. Are you presently taking any oral enzyme therapy?
___ Yes
___ No
If the answer to #1 above is No, please answer questions below – thank you.

2. With your current knowledge regarding oral enzyme therapy, what is the likelihood that you
would use enzyme therapy along with your chemotherapy?
0

1

2

3

4

5

6

7

8

9

Would Not
Use

10
Would
Use

3. With your current knowledge regarding oral enzyme therapy, if you were taking enzyme
therapy and your health care provider advised you to stop them what is the likelihood you
would you stop them?
0

1

2

3

4

5

6

7

8

9

Would Not
Stop

10
Would
Stop

4. With your current knowledge regarding oral enzyme therapy, what is the likelihood that you
would participate in a research study using oral enzyme therapy with your chemotherapy?
0

1

Would Not
Participate

2

3

4

5

6

7

8

9

10

Would
Not Participate

